CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRISPR Therapeutics AG (CRSP)
Today's Latest Price: $188.49 USD
Updated Jan 22 4:00pm
Add CRSP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CRSP Stock Summary
- CRSP's price/sales ratio is 169.04; that's higher than the P/S ratio of 97.39% of US stocks.
- Over the past twelve months, CRSP has reported earnings growth of 1,884.94%, putting it ahead of 99.41% of US stocks in our set.
- As for revenue growth, note that CRSP's revenue has grown -63.62% over the past 12 months; that beats the revenue growth of only 3.14% of US companies in our set.
- Stocks that are quantitatively similar to CRSP, based on their financial statements, market capitalization, and price volatility, are ARGX, DNLI, ZYME, MEIP, and ARVN.
- CRSP's SEC filings can be seen here. And to visit CRISPR Therapeutics AG's official web site, go to www.crisprtx.com.
CRSP Stock Price Chart Interactive Chart >
CRSP Price/Volume Stats
| Current price | $188.49 | 52-week high | $220.20 |
| Prev. close | $185.10 | 52-week low | $32.30 |
| Day low | $182.25 | Volume | 1,794,700 |
| Day high | $190.03 | Avg. volume | 2,651,643 |
| 50-day MA | $149.98 | Dividend yield | N/A |
| 200-day MA | $96.70 | Market Cap | 13.42B |
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
Loading social stream, please wait...